Pneumonia Caused by Mycobacterium shimoidei: An Uncommon Non-Tuberculous Mycobacterial Infection in a Young Woman with Anorexia Nervosa - Scorecard - MDSpire
Advertisement
Pneumonia Caused by Mycobacterium shimoidei: An Uncommon Non-Tuberculous Mycobacterial Infection in a Young Woman with Anorexia Nervosa
Clinical Scorecard: Pneumonia Caused by Mycobacterium shimoidei: An Uncommon Non-Tuberculous Mycobacterial Infection in a Young Woman with Anorexia Nervosa
At a Glance
Category
Detail
Condition
Pulmonary infection caused by Mycobacterium shimoidei, a rare non-tuberculous mycobacterium
Key Mechanisms
Infection occurs primarily in immunocompromised hosts or those with risk factors such as structural lung damage or weakened immunity; diagnosis requires microbiological confirmation including next-generation sequencing
Target Population
Immunocompromised individuals, patients with structural lung abnormalities, and those with conditions causing immune weakness such as severe anorexia nervosa
Care Setting
Critical care and specialized infectious disease units with access to advanced microbiological diagnostics and long-term antimicrobial therapy monitoring
Key Highlights
Mycobacterium shimoidei is a rare NTM causing cavitary pulmonary disease, often underdiagnosed due to diagnostic challenges.
Next-generation sequencing enables rapid and accurate identification of M. shimoidei, facilitating timely targeted therapy.
Severe anorexia nervosa can be a significant risk factor for NTM pulmonary infections due to immune suppression.
Guideline-Based Recommendations
Diagnosis
Perform microbiological confirmation for suspected NTM pulmonary disease using microscopy, culture, PCR, and next-generation sequencing.
Use chest CT imaging to identify cavitary lesions but do not rely solely on imaging to differentiate NTM from tuberculosis.
Consider next-generation sequencing for rapid and comprehensive mycobacterial species identification.
Management
Initiate combination antimicrobial therapy tailored to susceptibility testing, commonly including macrolides, ethambutol, and rifamycins.
Adjust antibiotic dosing based on renal function and nutritional status to minimize toxicity.
Consider switching antibiotics (e.g., from clarithromycin to moxifloxacin) to improve side effect profiles in patients with renal insufficiency.
Monitoring & Follow-up
Perform regular clinical evaluations and laboratory monitoring including inflammatory markers and renal function throughout treatment.
Repeat sputum cultures to confirm microbiological clearance during therapy.
Use follow-up imaging to assess resolution of cavitary lesions and detect residual lung changes.
Risks
Immunosuppression and structural lung disease increase risk of NTM pulmonary infections.
Delayed diagnosis may occur due to rarity and slow culture growth of M. shimoidei.
Potential antibiotic toxicity especially in patients with renal impairment and malnutrition.
Patient & Prescribing Data
A 37-year-old woman with severe anorexia nervosa and chronic kidney disease
Combination therapy with clarithromycin, ethambutol, and rifabutin was effective; clarithromycin was replaced by moxifloxacin after 4 weeks due to renal insufficiency and side effect concerns; total treatment duration was 12 months with clinical and microbiological improvement.
Clinical Best Practices
Use advanced molecular diagnostics such as next-generation sequencing for rapid identification of rare NTM species.
Tailor antimicrobial therapy based on susceptibility testing and patient-specific factors including renal function and nutritional status.
Maintain prolonged combination antibiotic therapy (up to 12 months) with close clinical and microbiological monitoring.
Recognize severe anorexia nervosa as a potential risk factor for NTM infections due to immune compromise.
Implement multidisciplinary care involving infectious disease specialists, pulmonologists, and nutritionists.
